nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer
|
Polley, Mei-Yin C. |
|
|
185 |
3 |
p. 557-566 |
artikel |
2 |
A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer
|
Brezden-Masley, Christine |
|
|
185 |
3 |
p. 807-815 |
artikel |
3 |
A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management
|
Shah, Hely |
|
|
185 |
3 |
p. 533-547 |
artikel |
4 |
Association between statin use and second cancer risk in breast cancer patients: a nationwide population-based cohort study
|
Lu, Yin-Che |
|
|
185 |
3 |
p. 773-783 |
artikel |
5 |
Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis
|
Wen, Yaokai |
|
|
185 |
3 |
p. 799-806 |
artikel |
6 |
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
|
Garcia-Tejedor, Amparo |
|
|
185 |
3 |
p. 657-666 |
artikel |
7 |
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer
|
Chobrutskiy, Andrea |
|
|
185 |
3 |
p. 591-600 |
artikel |
8 |
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
|
Dackus, Gwen M. H. E. |
|
|
185 |
3 |
p. 817-830 |
artikel |
9 |
Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
|
Braal, C. Louwrens |
|
|
185 |
3 |
p. 889 |
artikel |
10 |
Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations
|
Katz, Matthew S. |
|
|
185 |
3 |
p. 891 |
artikel |
11 |
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial
|
Rabaglio, Manuela |
|
|
185 |
3 |
p. 697-707 |
artikel |
12 |
Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features
|
Llanos, Adana A. M. |
|
|
185 |
3 |
p. 785-798 |
artikel |
13 |
Implant-based breast reconstruction: re-analysis of the odds ratio for skin flap necrosis
|
Messori, Andrea |
|
|
185 |
3 |
p. 887 |
artikel |
14 |
Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial
|
Raphael Daniela, D. B. |
|
|
185 |
3 |
p. 685-695 |
artikel |
15 |
Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American women
|
Shaik, Asra N. |
|
|
185 |
3 |
p. 831-839 |
artikel |
16 |
Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging?
|
Schumacher, Katelyn |
|
|
185 |
3 |
p. 567-572 |
artikel |
17 |
Letter to the editor regarding the article “Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer”
|
Chen, Xishan |
|
|
185 |
3 |
p. 883 |
artikel |
18 |
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function
|
Khoury, Katia |
|
|
185 |
3 |
p. 863-868 |
artikel |
19 |
Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution
|
Li, Xiaoxian |
|
|
185 |
3 |
p. 573-581 |
artikel |
20 |
Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)
|
Clifton, Katherine |
|
|
185 |
3 |
p. 639-646 |
artikel |
21 |
New anti-HER2 agents for brain metastasis: histology-agnostic weapons?
|
Tarantino, Paolo |
|
|
185 |
3 |
p. 879-881 |
artikel |
22 |
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer
|
Elsharawy, Khloud A. |
|
|
185 |
3 |
p. 615-627 |
artikel |
23 |
Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray
|
Parks, R. M. |
|
|
185 |
3 |
p. 647-655 |
artikel |
24 |
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase
|
Sachdev, Jasgit C. |
|
|
185 |
3 |
p. 759-771 |
artikel |
25 |
Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients
|
Gomes, Renan |
|
|
185 |
3 |
p. 851-861 |
artikel |
26 |
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial
|
Lugtenberg, Rieneke T. |
|
|
185 |
3 |
p. 741-758 |
artikel |
27 |
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes
|
Zhao, Fangyuan |
|
|
185 |
3 |
p. 841-849 |
artikel |
28 |
Re: Naoum et al., Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy
|
Alipour, Sadaf |
|
|
185 |
3 |
p. 885-886 |
artikel |
29 |
The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis
|
Weiser, Roi |
|
|
185 |
3 |
p. 667-676 |
artikel |
30 |
The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements
|
Shah, Chirag |
|
|
185 |
3 |
p. 709-740 |
artikel |
31 |
The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer
|
Yang, Ciyu |
|
|
185 |
3 |
p. 869-877 |
artikel |
32 |
The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer
|
Tropée, Romain |
|
|
185 |
3 |
p. 601-614 |
artikel |
33 |
The wisdom trial is based on faulty reasoning and has major design and execution problems
|
Kopans, Daniel B. |
|
|
185 |
3 |
p. 549-556 |
artikel |
34 |
To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
|
Herbert, S. L. |
|
|
185 |
3 |
p. 677-684 |
artikel |
35 |
Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy
|
Liu, Shiwei |
|
|
185 |
3 |
p. 629-638 |
artikel |
36 |
Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients
|
Lattimore, Vanessa |
|
|
185 |
3 |
p. 583-590 |
artikel |